TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/16/09 15:57 | 9/3/09 | PPCO | Penwest Pharmaceuticals Co | WA | Health | Drug | Pharmaceutical Preparations | Freiman Paul E | CT | D | S | -8 | 2.35 | 0 | -3 | -11 | 29 | D | |||||||||||||||
2/12/09 21:08 | 12/10/08 | NTII | Neurobiological Technologies Inc /ca/ | DE | Health | BioPrd | Biological Products, (No Diag | Freiman Paul E | CA | H | Former o | S.m | -1 | 0.5145 | 0 | -2 | -14 | 15 | |||||||||||||||
6/12/08 14:25 | 6/10/08 | PPCO | Penwest Pharmaceuticals Co | WA | Health | Drug | Pharmaceutical Preparations | Freiman Paul E | CT | D | S | -15 | 3.09 | 0 | -5 | -17 | 24 | D | |||||||||||||||
5/23/08 14:45 | 5/12/08 | PPCO | Penwest Pharmaceuticals Co | WA | Health | Drug | Pharmaceutical Preparations | Freiman Paul E | CT | D | S | -11 | 2.64 | 0 | -4 | -12 | 28 | D | |||||||||||||||
2/23/07 15:03 | 2/21/07 | NTII | Neurobiological Technologies Inc /ca/ | DE | Health | BioPrd | Biological Products, (No Diag | Freiman Paul E | CA | DO | P,CEO | S.dm | -265 | 2.65 | 0 | -100 | -50 | 101 | D | ||||||||||||||
5/3/06 13:51 | 5/1/06 | PPCO | Penwest Pharmaceuticals Co | WA | Health | Drug | Pharmaceutical Preparations | Freiman Paul E | CT | D | S | -199 | 19.90 | 0 | -10 | -45 | 12 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |